Cargando…
Host-directed therapy with 2-deoxy-D-glucose inhibits human rhinoviruses, endemic coronaviruses, and SARS-CoV-2
Rhinoviruses (RVs) and coronaviruses (CoVs) upregulate host cell metabolic pathways such as glycolysis to meet their bioenergetic demands for rapid multiplication. Using the glycolysis inhibitor 2-deoxy-d-glucose (2-DG), we assessed the dose-dependent inhibition of viral replication of minor- and ma...
Autores principales: | Wali, Laxmikant, Karbiener, Michael, Chou, Scharon, Kovtunyk, Vitalii, Adonyi, Adam, Gösler, Irene, Contreras, Ximena, Stoeva, Delyana, Blaas, Dieter, Stöckl, Johannes, Kreil, Thomas R., Gualdoni, Guido A., Gorki, Anna-Dorothea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731833/ https://www.ncbi.nlm.nih.gov/pubmed/36514716 http://dx.doi.org/10.1016/j.jve.2022.100305 |
Ejemplares similares
-
In vitro RNA release from a human rhinovirus monitored by means of a molecular beacon and chip electrophoresis
por: Weiss, Victor U., et al.
Publicado: (2016) -
Erratum to: In vitro RNA release from a human rhinovirus monitored by means of a molecular beacon and chip electrophoresis
por: Weiss, Victor U., et al.
Publicado: (2016) -
Mechanism of human rhinovirus infections
por: Blaas, Dieter, et al.
Publicado: (2016) -
Productive Entry Pathways of Human Rhinoviruses
por: Fuchs, Renate, et al.
Publicado: (2012) -
Rhinovirus Inhibitors: Including a New Target, the Viral RNA
por: Real-Hohn, Antonio, et al.
Publicado: (2021)